Advertisement
Screener

NEUROMETRIX, INC. Net Change in Cash

NEUROMETRIX, INC. Net Change in Cash

NEUROMETRIX, INC. reported Net Change in Cash of -$304.16 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.

Financial Statements › Cash Flow

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2025-03-31

  • NEUROMETRIX, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$472.02K.
  • NEUROMETRIX, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$1.96M, a 263.57% decline year-over-year.
  • NEUROMETRIX, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was $1.20M.
  • NEUROMETRIX, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was -$81.05K.
  • NEUROMETRIX, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$304.16K.
  • NEUROMETRIX, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$2.60M.
  • NEUROMETRIX, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$18.24M, a 205.14% decline from fiscal 2021.
  • NEUROMETRIX, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $17.35M, a 725.99% increase from fiscal 2020.
Period endCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month as first filed
2024-12-31-$304.16K
10-K · filed 2025-03-31
2024-09-30-$810.43K
10-Q · filed 2024-11-05
2024-06-30-$124.97K
10-Q · filed 2024-08-06
2024-03-31-$472.02K
10-Q · filed 2024-05-15
2023-12-31-$2.60M
10-K · filed 2025-03-31
2023-09-30-$2.87M
10-Q · filed 2024-11-05
2023-06-30-$2.47M
10-Q · filed 2024-08-06
2023-03-31-$1.96M
10-Q · filed 2024-05-15
2022-12-31-$18.24M
10-K · filed 2024-03-01
-$18.32M
10-K · filed 2023-03-22
2022-09-30-$20.80M
10-Q · filed 2023-10-26
2022-06-30-$16.57M
10-Q · filed 2023-07-27
2022-03-31$1.20M
10-Q · filed 2023-05-03
2021-12-31$17.35M
10-K · filed 2023-03-22
2021-09-30$17.99M
10-Q · filed 2022-10-20
2021-06-30$3.14M
10-Q · filed 2022-07-21
2021-03-31-$81.05K
10-Q · filed 2022-04-26
2020-12-31$2.10M
10-K · filed 2022-01-28
2020-09-30$1.80M
10-Q · filed 2021-10-21
2020-06-30$2.31M
10-Q · filed 2021-07-22
2020-03-31-$309.72K
10-Q · filed 2021-04-22
2019-12-31-$3.65M
10-K · filed 2021-01-29
2019-09-30-$3.59M
10-Q · filed 2020-10-22
2019-06-30-$1.82M
10-Q · filed 2020-07-23
2019-03-31$420.37K
10-Q · filed 2020-04-23
2018-12-31$2.74M
10-K · filed 2020-01-28
2018-09-30$3.49M
10-Q · filed 2019-10-17
2018-06-30$3.07M
10-Q · filed 2019-07-18
2018-03-31$2.05M
10-Q · filed 2019-04-25
2017-12-31$94.55K
10-K · filed 2019-01-24